Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03316261 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Freder1k-Study - Testing Infants for Type 1 Diabetes Risk

StatusRecruiting
PhaseNot specified
Started2017-10-19
View on ClinicalTrials.gov ↗
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.

Amendment record

Amended 8 times since 2017-10-19; most recent filed 2024-12-12. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2024-12-12
Amendment Study Status, Study Design, Outcome Measures, Eligibility v8
2023-09-21
Amendment Study Status v7
2022-03-15
Amendment Study Status v6
2021-02-05
Amendment Study Status, Study Design, Outcome Measures, Eligibility v5
2020-07-28
Amendment Study Status, Eligibility, Contacts/Locations, References v4
2019-06-24
Amendment Study Status v3
2018-02-22
Amendment Study Status v2
2017-11-17
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
2017-10-19
Original filing
Trial Details
NCT Number NCT03316261
Lead Sponsor Helmholtz Zentrum München
Conditions Identification of Infants at Risk for Type 1 Diabetes
Enrollment 1,000,000 participants
Start Date 2017-10-19
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2024-12-17